Related Experiment Video
Updated: Jun 5, 2026
07:26
Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Septic encephalopathy: inflammation in man and mouse.
Alexander Jacob1, James R Brorson, Jessy J Alexander
1Department of Medicine, University of Chicago, Chicago, IL 60637, USA. jalexand@medicine.bsd.uchicago.edu
Neurochemistry International
|January 12, 2011
Summary
Septic encephalopathy (SE) is a serious brain complication of sepsis. Understanding inflammatory mediators like cytokines and complement proteins may lead to new therapies for this neurological dysfunction.
Area of Science:
- Neuroscience
- Immunology
- Critical Care Medicine
Background:
- Septic encephalopathy (SE) is a common neurological complication of sepsis.
- Current treatments lack the ability to prevent or treat SE-induced brain dysfunction.
- The precise cellular and molecular mechanisms underlying SE remain poorly understood.
Purpose of the Study:
- To review current understanding of SE pathology mechanisms.
- To emphasize the role of inflammatory and excitatory mediators.
- To explore potential therapeutic targets for SE.
Main Methods:
- Literature review of studies on septic encephalopathy mechanisms.
- Focus on inflammatory mediators (cytokines, chemokines, complement).
- Analysis of neurotransmitter involvement and therapeutic potential.
Main Results:
- Inflammation, including cytokines and complement, plays a key role in SE.
- Animal studies show promise in alleviating brain dysfunction by regulating these mediators.
- Neurotransmitters are also implicated in SE pathogenesis.
Conclusions:
- Understanding inflammatory and excitatory mediators is crucial for SE.
- Cytokines, complement proteins, and neurotransmitters represent potential therapeutic targets.
- Further research may lead to novel treatments for sepsis-induced brain damage.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...